Expanding horizons for the targeted management of EGFR-mutant NSCLC

Learning objective:         

After watching this broadcast, participants should be able to:

• Reflect on recent developments in the molecular diagnosis of EGFR-mutant NSCLC
• Describe updates in the management of advanced EGFR-mutant NSCLC
• Evaluate the use of novel emerging therapeutic options for EGFR exon 20 insertion mutations and their implementation into clinical practice

Faculty:

• Martin Reck (Germany)
• Umberto Malapelle (Italy)
• Maximilian Hochmair (Austria)
• Sabine Merkelbach-Bruse (Germany)
• Jordi Remon (Spain)

Claim your CPD credits

The content of the following has been certified by the CPD Certification Service as conforming to continuing professional development principles.

You can claim 1.0 credits for this activity.

Please make a note of the below information to claim your points.

Name of activity: Expanding horizons for the targeted management of EGFR-mutant NSCLC, 7 August 2022, Vienna

Certificate number: A038286

Date of activity: October 2022

CPD Provider: Sciterion 013096